Literature DB >> 10746486

The prevalence of multiple diabetes-related complications.

C L Morgan1, C J Currie, N C Stott, M Smithers, C C Butler, J R Peters.   

Abstract

AIMS: To determine the prevalence of the complications of diabetes and the interrelationship between them within a United Kingdom district health authority population.
METHODS: Data extracted from a general practice diabetes audit were combined with data for patients with diabetes derived from a patient index constructed using record linkage techniques.
RESULTS: A total of 10709 patients were identified as having diabetes (prevalence 2.47%). Coronary heart disease was present in 25.2%, cerebrovascular disease in 9.6%, complications of the 'diabetic foot' in 18.1%, retinopathy in 16.5% and nephropathy in 2.0%. Over a half of the patients (52.1%) had none of the studied complications, 30.2% had one, 12.7% had two, 4.1% had three, 0.8% had four and 0.1% had all five. All complications were related to both age and duration of diabetes but duration was particularly apparent for the microvascular complications (retinopathy and nephropathy). Macrovascular complications in the Type 2 diabetic population appear advanced in onset compared with Type 1.
CONCLUSIONS: Multiple complications are apparent in almost one fifth of patients with diabetes. Macrovascular morbidity in Type 2 diabetes of early onset indicates that a targeted approach to treatment may prove most beneficial in both patient and health service terms.

Entities:  

Mesh:

Year:  2000        PMID: 10746486     DOI: 10.1046/j.1464-5491.2000.00222.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  32 in total

Review 1.  Exercise training: can it improve cardiovascular health in patients with type 2 diabetes?

Authors:  K J Stewart
Journal:  Br J Sports Med       Date:  2004-06       Impact factor: 13.800

Review 2.  Endothelial dysfunction as a potential contributor in diabetic nephropathy.

Authors:  Takahiko Nakagawa; Katsuyuki Tanabe; Byron P Croker; Richard J Johnson; Maria B Grant; Tomoki Kosugi; Qiuhong Li
Journal:  Nat Rev Nephrol       Date:  2010-11-02       Impact factor: 28.314

3.  Requisite models for strategic commissioning: the example of type 1 diabetes.

Authors:  Mara Airoldi; Gwyn Bevan; Alec Morton; Mónica Oliveira; Jenifer Smith
Journal:  Health Care Manag Sci       Date:  2008-06

4.  Pioglitazone and cardiovascular risk in T2DM patients: is it good for all?

Authors:  Muhammad Abdul-Ghani; Amin Jayyous; Nidal Asaad; Sherif Helmy; Jassim Al-Suwaidi
Journal:  Ann Transl Med       Date:  2018-05

5.  SIRT3 protects endothelial cells from high glucose-induced cytotoxicity.

Authors:  Guodong Liu; Mingming Cao; Ying Xu; Yanbo Li
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

6.  United Kingdom National Ophthalmology Database Study: Diabetic Retinopathy; Report 1: prevalence of centre-involving diabetic macular oedema and other grades of maculopathy and retinopathy in hospital eye services.

Authors:  T D L Keenan; R L Johnston; P H J Donachie; J M Sparrow; I M Stratton; P Scanlon
Journal:  Eye (Lond)       Date:  2013-09-20       Impact factor: 3.775

Review 7.  Vision-specific instruments for the assessment of health-related quality of life and visual functioning: a literature review.

Authors:  Mary Kay Margolis; Karin Coyne; Tessa Kennedy-Martin; Timothy Baker; Oliver Schein; Dennis A Revicki
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

8.  Complications in Advanced Diabetics in a Tertiary Care Centre: A Retrospective Registry-Based Study.

Authors:  Amit Dias; Edwin Gomes; Ankush Dessai
Journal:  J Clin Diagn Res       Date:  2016-04-01

9.  Prevalence of chronic complications of type 2 diabetes mellitus in outpatients - a cross-sectional hospital based survey in urban China.

Authors:  Zhaolan Liu; Chaowei Fu; Weibing Wang; Biao Xu
Journal:  Health Qual Life Outcomes       Date:  2010-06-26       Impact factor: 3.186

10.  Adherence to guidelines and its effects on hospitalizations with complications of type 2 diabetes.

Authors:  Frank A Sloan; M Angelyn Bethel; Paul P Lee; Derek S Brown; Mark N Feinglos
Journal:  Rev Diabet Stud       Date:  2004-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.